Brentuximab Vedotin + Rituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Brentuximab Vedotin + Rituximab, covering 2021-01-05 to 2021-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas [Phase 1, Phase 2]